Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists?

Hernández MV, Ruiz-Esquide V, Gómez-Caballero ME, Gómez-Puerta JA, Cañete JD, Sanmartí R. Relapsing polychondritis: a new adverse event secondary to the use of tumour necrosis factor antagonists? Rheumatology (Oxford). 2011 Aug; 50(8):1523-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.